This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Expanscience. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David Durancet: Innovator in Dermatological Solutions
Introduction
David Durancet is a notable inventor based in Saint Cyr L'Ecole, France. He has made significant contributions to the field of dermatology, particularly in the treatment of conditions caused by yeast infections. His innovative approach has led to the development of a unique composition aimed at inhibiting the growth of yeasts involved in cradle cap and other related conditions.
Latest Patents
David Durancet holds 1 patent for his invention titled "Composition comprising at least one oxazoline for inhibiting the growth of yeasts involved in cradle cap." This patent describes a composition that includes at least one oxazoline, such as OX100, which is effective in preventing and treating conditions caused by yeasts, including seborrheic dermatitis, cradle cap, folliculitis, and dandruff. The invention also incorporates additional compounds like malic acid diester and vegetable oil oleodistillate, enhancing its efficacy in treating these conditions.
Career Highlights
Durancet's career is marked by his dedication to research and innovation in dermatological solutions. His work at Laboratoires Expanscience has allowed him to focus on developing effective treatments that address common skin issues. His contributions have not only advanced the field but have also provided relief to many individuals suffering from these conditions.
Collaborations
David has collaborated with esteemed colleagues such as Stephanie Bredif and Sophie Leclere-Bienfait. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and innovations.
Conclusion
David Durancet's work exemplifies the impact of innovation in the field of dermatology. His patented composition represents a significant advancement in the treatment of yeast-related skin conditions, showcasing his commitment to improving patient care.